Targeted blockade of JAK/STAT3 signaling inhibits proliferation, migration and collagen production as well as inducing the apoptosis of hepatic stellate cells
Authors:
- 26 July 2016
- journal article
- research article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 38 (3) , 903-911
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 53 references indexed in Scilit:
- Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedsideThe Journal of Biochemistry, 2015
- The many faces of Janus kinaseBiochemical Pharmacology, 2012
- Therapeutic targets in liver fibrosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- JAK-STAT signaling in hepatic fibrosisFrontiers in Bioscience-Landmark, 2011
- JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitationsLeukemia, 2010
- Acidic Sphingomyelinase Controls Hepatic Stellate Cell Activation and in Vivo Liver FibrogenesisThe American Journal of Pathology, 2010
- TGF-β1 Gene Silencing for Treating Liver FibrosisMolecular Pharmaceutics, 2009
- Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?Liver International, 2009
- Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine dataThe Lancet, 2006
- Signaling through the JAK/STAT pathway, recent advances and future challengesGene, 2002